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The choledocho-choledochostomy stricture is one of the most frequent complications occurring after
liver transplantation. Today endoscopic retrograde cholangiopancreatographymay be consideredone
of the most common methodologic approaches for the diagnosis; at the same time it provides an ef-
fective treatment of the stenosis, avoiding more invasive surgery. Biliary flow through a strictured
anastomosis definitely improves after endoscopic stenting which, in most cases, resolves the biliary
obstruction syndrome; moreover, the stent could allow restoration of the anatomical and functional
integrity of the common bile duct. We have successfully treated eight liver transplanted patients with
biliary anastomotic stenosis by endoscopic stenting of the common bile duct or by balloon dilation
(one patient). The stents were replaced every 3 to 4 months and then removed after year of follow-
up. We observed one patient with acute cholangitis due to the clogging of the prosthetic device.
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INTRODUCTION
Reconstruction of the common bile duct during a liver
transplantation (OLTX) is a very critical stage of the op-
eration: usually it is accomplished by end-to-end chole-
docho-choledochostomy (CCS) (1). The CCS itself may
develop a series ofearly or late complications, such as bile
leaks (subhepatic biloma), sludge or stones, mucocele of
the cystic duct remnant, and anastomotic strictures (1-9).
In the literature, the overall complication rate ranges from
10 to 25% (1-5,7,9,10); the onset is higher within the first
3 months afterOLTX (2-9). Anastomotic stenoses repre-
sent one-third of the complications.
A clinically significant stenosis results in a corre-
sponding biliary obstruction syndrome (BOS), which can
be detectedby specific laboratory findings. In someOLTX
patients morphological evidence for a dilated biliary tree
above the stenosis may be lacking. In addition, dilation of
the recipient common bile duct may be found (1).
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Endoscopic retrograde cholangiopancreatography
(ERCP) is a commonly used method for morphological
and functional evaluation of the biliary ducts after liver
transplantation (6,8). In addition, it could provide less in-
vasive treatment of stenosis characterized by impairment
of the bile flow.
The aim of our study was to verify the possible thera-
peutic role of biliary operative endoscopy in OLTX pa-
tients with CCS stenosis.
METHODS AND PATIENTS
Ten of 160 patients withOLTX (6.25%) underwentERCP
because ofBOS (Figs. to 4) with orwithout evidentjaun-
dice. Etiological and biological features of patients are
shown in Table 1. Serum bilirubin levels ranged from 2.10
to 13.50 mg/dl (mean value 4.61 mg/dl). Stenosis of the
end-to-end CCS was found in eight patients. Only two of
them had mildly dilated biliary trees upstream. The fol-
lowing treatments were performed on the eight stenotic
patients:94 A. ROSSI et al.
Figure Stricture of choledocho-choledochostomy in a liver-
transplanted patient: dilated biliary tree above the stenosis.
Figure 2 A strictured choledocho-choledochostomy without dilatation
oftheupstream biliary ducts.A stonemay be seen in the recipientcommon
bile duct.
One patient: balloon dilation (PEG-7-38-6, Wilson-Cook
Medical Inc., Winston-Salem, NC); the balloon, 8-mm
size and filled with distilled water, was inflated at 9 atm
pressure for minute.
Six patients: stenting with single OF prosthesis (Cotton-
Huibregtse type, Wilson-Cook Medical Inc.) (Fig. 5);
One patient: stenting with a double prosthetic device, 10
+ 7 F (Cotton-Huibregtse type, Wilson-Cook Medical
Inc.).
The balloon dilation and the double stent placement re-
quired previous endoscopic papillotomy. Endoscopic pro-
cedures were performed with the JF-1 T20 side-viewing
duodenoscope (Olympus Corp., Lake Success, NY).
Informed consent was obtained.
The efficacy of the biliary drainage was evaluated by
improvement of the BOS 7 days after the endoscopic pro-
cedure. The follow-up schedule required substitution of
the stents every 3 to 4 months and definitive removal after
year, unless complications occurred (Fig. 6).
RESULTS
In all cases the BOS was improved within the 7th day after
stenting: jaundice disappeared in seven patients, while in
one patient the bilirubin level decreased from 11.4 to 2.3
mg/dl. Table 2 summarizes what happened for each pa-
tient during the follow-up period.
Canalization of the stenotic tract was achieved for the
patient treated with balloon dilation at the first attempt,
and there were no recurrences (control by ERCP at 4.5
months) or complications until the end of his follow-up (9
months). Three ofthe six patients treated with a single OF
stent finished the established program. These patientsENDOSCOPY FOR ANASTOMOTIC BILIARY STENOSIS 95
Figure 3 Severe anastomotic stricture in OLTX patient: trans-Kehr
cholangiography shows complete stop of contrast medium.
Figure 4 After ERCP a guide-wire is inserted through the stricture,
reaching the left hepatic duct (same patient as Fig. 3).
were always symptom-free, without clinical or biohu-
moral evidence of BOS. One patient had acute cholangi-
tis 20 days alter stenting; clogging, with obstruction of the
stent, was found by ERCP. The obstructed device was re-
placed with a new one of the same size, after which the
septic condition rapidly improved. The patient had acute
hepatic rejection in the 3rd month of follow-up and was
given another transplant. The last two patients have not
yet been followed-up for more than 3 months.
The patient treated with double stenting had a replace-
ment with a single OF stent at 4 months, then another re-
placement at 7 months. Finally, the stent was removed at
10 months, without any complications and the patient is
now symptom-free.
DISCUSSION
The onset ofevident biliary obstruction in aOLTX patient
could immediately lead one to think of a possible hepatic
Table 1 Clinical and Biological Features of 10 OLTX Patients with
BOS
Value
Number of patients 10
Sex: M/F 6/4
Age (yr)
Range 31-55
Mean 46
Etiology of liver disease
Cirrhosis, hepatitis C virus 3
Cirrhosis, hepatitis B-D virus 2
Primary biliary cirrhosis
Cirrhosis + hepatocellular carcinoma 4
Serum bilirubin level (mg/dl)
Range 2.10-13.50
Mean 4.61
rejection. However, in some cases it may more simply be
due to a stenosis of the choledocho-choledochostomy.
Postoperative strictures in OLTX patients seem to be
independent of either the most common etiopatho-96 A. ROSSI et al.
Figure 5 Stenting is performed by a 10F polyethylene device (same
patient as Fig. 3). Figure 6 Twelve months after the first stenting procedure: the last
stent is removed and the choledocho-choledochostomy is well canalized
(same patient as Fig. 3).
genetic factors connected to the hepatic disease or in-
fectious or pharmacological situations. The main cause
of this complication, apart from technical problems, is
probably the unfavorable blood supply to the biliary
tract.3 ERCP is therefore an important diagnostic pro-
cedure for these patients and moreover it offers an ef-
fective and relatively noninvasive treatment of the
stenosis itself.6,2
The CCS stenosis may be classified as "not neoplas-
tic" and, if so, it could be treated with the same endo-
scopic procedures that have been codified for the most
classical model of "benign stenosis" of the common bile
duct, that is, the postcholecystectomy stricture. 3
Following this guideline we used both balloon dilation
and, above all, the polyethylene prosthesis. Stenting
seems to offer better advantages, as well as a lower risk
of complications. This procedure in fact enhances biliary
Table 2 Endoscopic Treatment and Follow-up of Eight OLTX
Patients with Symptomatic Anastomotic Stricture.
No. of patients
Therapy
Follow-up:
month
2
3
4
5
6
7
8
9
10
11
12
13
balloon
ERCP
6
stent.
Ch
LRej
2 stent
(1 tent)
Abbreviations: Ch, acute cholangitis; LRej, liver rejection; *, stent replacement;
***, stent removal; _L, end of follow-up with patient being well.ENDOSCOPY FOR ANASTOMOTIC BILIARY STENOSIS 97
flow so that the BOS can rapidly improve. Moreover, it
may allow the common bile duct to rebuild itself around
the stent, which in this way becomes a sort of plastic
mold: after 10 to 12 months of stenting, the CCS could
be wide enough to permit an adequate biliary flow. In our
experience, at the end of follow-up schedule ERCP
showed a well-canalized CCS, and patients were clini-
cally asymptomatic. Prolonged clinical observation
would be necessary to establish the long-term efficacy of
this procedure.
In the majority of our patients, ERCP showed small-
sized biliary trees above the stricture. This might be due
to early and temporary edema and infiltration of the por-
tal tract of the transplanted liver, although a conclusive
explanation is still lacking. However, this finding should
be differentiated from the so-called "vanishing bile duct
syndrome". This nosological entity, recently described in
the literature (14), is defined as disappearance of biliary
ducts. It can be seen even histologically and may be con-
sidered a particular type of liver rejection. Arterial throm-
bosis is another pathogenesis to be suspected in the
presence of single or multiple stenosis of bile ducts in a
transplanted liver.
Because of the above-mentioned small size of the com-
mon bile duct, we preferred to use single 10F stents. Only
one patientwas given adouble 10+ 7F stent. Nevertheless,
we did not find any delay or limiting of the canalization
of strictures.
Finally, we want to emphasize the need for periodically
planned replacement of the stents to reduce the risk of
clogging and avoid the consequent cholangitis, which is a
particularly dreadful event in OLTX patients treated with
immunosuppressive drugs.
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